Allergy is a harmful immune response by the body to substances such as pollens, specific food, and dust, which are responsible for hypersensitivity. Food allergy, inhaled allergy, and drug allergy are the common types of allergies. Leukotriene inhibitors, also called leukotriene modifiers, are drugs given to treat allergic rhinitis or allergies. These are also prescribed to prevent asthma. Leukotriene inhibitors block or inhibit the action of leukotrienes. Leukotrienes are inflammatory chemicals secreted by various cells in the body such as mast cells, macrophages, eosinophils, and basophils. They are the most potent broncoconstrictors identified in humans. Leukotriene secretion causes airway edema, mucous secretion, smooth muscle contraction, altered cellular activity associated with the inflammatory process, and micro vascular permeability. Leukotrienes are usually secreted when the body comes in contact with an allergen or allergy inducing agents such as pollen and dust particles. These chemicals, when secreted, lead to tightening of airway muscles and excess fluid and mucus production. This makes it difficult to breathe.

Increase in prevalence of allergic diseases is the key factor driving the global leukotriene inhibitors market. In 2015, prevalence of allergic diseases across the globe stood at approximately 30%, which is about 1 billion people. According to a study published by the European Academy of Allergy and Clinical Immunology (EAACI) allergy was the most common chronic disease in Europe in 2016. According to “The Burden of Asthma 2013,” a report published by the Global Asthma Network, the prevalence of allergy in Western countries and other developed countries is higher than that in developing countries. Changing lifestyle pattern, genetic factors, and environmental changes amay increase the chances of getting allergic to various substances. Changing climatic conditions, increased level of pollution and carbon dioxide levels around the world has led to rise in prevalence of allergies. In 2012, 17.6 million adults and 6.6 million children were reported to suffer from allergic rhinitis.

The global leukotriene inhibitors market can be segmented based on drugs, distribution channels, and region. In terms of drugs, the global leukotriene inhibitors market can be divided into Montelukast (Singulair), Zafirlukast (Accolate), Zileuton (Zyflo), and Zileuton ER (Zyflo CR). The U.S. FDA has approved Montelukast (Singulair) for prophylaxis and chronic treatment of asthma in adults, and children above the age of one. Montelukast (Singulair) is also used in prevention of bronchoconstriction induced due to exercise. Similarly, Zafirlukast (Accolate), Zileuton (Zyflo), and Zileuton ER (Zyflo CR) are used in chronic treatment of asthma in adults, and children above five years and 12 years of age. Leukotriene inhibitors are used in the treatment of allergic rhinitis. Allergic rhinitis, the most common type of inhaled allergy, affects about 10% to 30% of the global population. About 7.8% of people who are 18 years and above in the U.S. suffer from allergic rhinitis. Based on distribution channel, the global leukotriene inhibitors market can be divided into hospital pharmacies, online pharmacies, retail pharmacies, and drug stores.

In terms of geography, the global leukotriene inhibitors market can be segregated into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Advancement in drug discovery and research technology is anticipated to boost the global leukotriene market during the forecast period. Various government initiatives and funding are also likely to augment the global leukotriene inhibitors market.

Key players operating in the global leukotriene inhibitors market include Stallergenes Greer, Circassia, GlaxoSmithKline plc, Sunovion Pharmaceuticals, Inc., and Merck Sharp & Dohme (a Merck & Co., Inc. company)

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Leukotriene Inhibitors Market

Pre Book